Deleted tweet detection is currently running at reduced
capacity due to changes to the Twitter API. Some tweets that have been
deleted by the tweet author may not be labeled as deleted in the PolitiTweet
interface.
Showing page 4 of 105.
Teva Pharmaceuticals @TevaUSA
@CHAMANS63758645 Thank you. Please submit your Code of Conduct concern to the Teva Integrity Hotline for appropriate handling and response. https://t.co/sFlWFDLthg — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
It’s #GlobalBiosimilarsWeek, and we’re raising awareness for #biosimilars and the important role they play in expanding access to care in healthcare systems around the globe. Discover the magic of biosimilars here: https://t.co/XTWTahK4YL #TevaBiosimilarsUnlockingValue #TevaUSA https://t.co/eurEnGWjNi — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Today, our Head of Digital Health and Innovation, Manny Montalvo, spoke on a panel at #HLTH2022 to discuss the bright future ahead in the #digitalhealth and digital therapeutics space. Thank you to @GoldsackJen, @judbrewer, and Faisel Khan for an inspiring discussion. https://t.co/QtYg6hVjse — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
RT @Lucienneide: #digitaltherapeutics panel at #HLTH2022 with @TevaUSA - digital therapeutics can’t interfere with #hcp workflows and need… — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Proud to host Governor Parson and the delegation of Missouri Israel Trade & Investment Office, Missouri Department of Economic Development at Teva’s SLE's logistic center in Shoham to discuss our mission of striving to improve the lives of patients worldwide. — PolitiTweet.org
Governor Mike Parson @GovParsonMO
Today, we visited the @TevaUSA global headquarters in Israel and got to tour the SLE distribution facility. We le… https://t.co/YpclCud2Zg
Teva Pharmaceuticals @TevaUSA
Live from #HLTH2022 — Our Sr. U.S. Medical Director, Respiratory and President of the @DHEHAlliance, Tanisha Hill, moderates a panel addressing digital determinants of health to improve access to care. https://t.co/zL2AHWlCRg — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Advancing #asthma care is important to us and exploring the potential of #digitalhealth solutions in asthma control is our north star in respiratory research. Thank you for joining us at #ACAAI22 to learn about our scientific progress in this area. — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
We’re excited to be a part of today’s #digitalhealth conversations. Come see us at #HLTH22 and learn about our latest collaborations advancing better data integration and predictive technologies. Learn more about this news here. https://t.co/6UtTVcGrAg https://t.co/XvGsrcvMvW — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
We’re excited to be a part of today’s #digitalhealth conversations. Come see us at #HLTH22 and learn about our latest collaborations advancing better data integration and predictive technologies. Learn more about this news here. https://t.co/6UtTVcGrAg https://t.co/fVMrQoqVDM — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Calling all #HLTH22 attendees — Join Teva’s Head of Digital Health and Innovation, Manny Montalvo, on the panel: Digital Therapeutics, Playing the Long Game. You won’t want to miss this! Join us at The Arena Stage on Nov. 14 at 3:30pm PST. — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Shachaf Reingewirtz is a chemist in the Quality Control lab at Teva’s manufacturing site in Kfar Saba, Israel. She ensures the high quality of Teva medications before they reach patients like Jaime, who has been suffering from chronic migraine. Watch here: https://t.co/lThztLm25u https://t.co/jsHQtHUaer — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Today at #ACAAI22 we’re proud to share our latest discoveries in #asthma management and the role #digitalhealth tools could play in treatment discussions. — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Proud to join Energize, a collaborative effort by the pharma industry and @SESustainable to increase access to renewable electricity for our suppliers. We’re committed to making a difference in our ESG journey. #Energize #COP27 #ClimateAction #RenewableEnergy — PolitiTweet.org
Schneider Electric Sustainability Business @SESustainable
We are thrilled to announce the #Energize pharmaceutical supply chain renewable energy program has formed its first… https://t.co/BqArInnGDx
Teva Pharmaceuticals @TevaUSA
Honored to be invited by the Israeli government delegation to represent Israel at the #COP27 conference yesterday where Amalia Adler Waxman, our Global Head of ESG, shared Teva's #ESG approach and the progress we are making. Read more:https://t.co/WmsBVEpdqi****** #ClimateAction https://t.co/mhripc1UAk — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
We are grateful to team Teva for coming together with key decisionmakers across the industry to improve patient access to high-quality medicines. — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Our policy and regulatory team members were out in full force at @AccessibleMeds #GRxBiosims this week to help shape the future of the generics and biosimilars industry. https://t.co/WAAgae41oq — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
We need better regulatory guidance and pathways for complex generics, notes Teva’s Janet Vaughn at @AccessibleMeds #GRxBiosims. It’s critical that FDA foster the development of complex generics in order to improve patient access. https://t.co/MXulXO9BKN — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Teva’s Janet Vaughn will be on stage soon @GRxBiosims to highlight regulatory barriers and opportunities for improvement within the complex generics space. https://t.co/OtN3p6UHjO — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
The passage of #BsUFA III showcases forward-thinking goals aimed at bringing biosimilars to market faster, improving patient access, and delivering savings across the system – Teva’s Cory Wohlbach states, live @AccessibleMeds #GRxBiosims https://t.co/e6GSbDpkR6 — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Cory Wohlbach is back onstage today at #GRxBiosims breaking down the Biosimilar User Fee Act (BsUFA III), recently reauthorized by Congress. Cory is shedding light on FDA’s new regulatory science pilot program aimed at advancing biosimilar products. https://t.co/AGjuOBAWi3 — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Christine Baeder, SVP, COO for US Generics at Teva and AAM Vice Chair shares a recap of the exciting happenings at #GRxBiosims 2022. She sat down with AAM to discuss the regulatory environment and the need for collaboration to pave the way for complex generics and biosimilars. — PolitiTweet.org
AAM @AccessibleMeds
"It's an exciting time to gather at GRx+Biosims 2022. No one mind can solve our problems, it really takes people co… https://t.co/XKoTv2Oh8U
Teva Pharmaceuticals @TevaUSA
What does the future of digital healthcare look like? What determines the success and value of a digital therapy? Join Teva’s Manny Montalvo at #HLTH22 for a panel discussion discussing the role Teva aims to play in transforming the next decade of healthcare. — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
There are many hurdles in biosimilar development, yet it’s critically important for the industry to forge ahead this critical category, says Teva’s Cory Wohlbach at #GRxBiosims. Biosimilars can help bring affordable medicines to patients and savings to the US healthcare system. https://t.co/THM4KT0uSP — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Legislation to improve therapeutic equivalence rating determination to drive access to complex generics was one of the many critical fixes left out of the UFA package, Teva’s Brian McCormick notes at #GRxBiosims https://t.co/I42TZTBhWX — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
RT @cecelou18: @US_FDA One of industry’s concerns with the IRA is ensuring “the continued incentives and growth of the generic and the bios… — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
Teva’s Cory Wohlbach is about to take the stage at #GRxBiosims to talk regulatory improvements that FDA can make to streamline biosimilar development and approval. https://t.co/ugcQZ0Li93 — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
The FDA User Fee Amendments passed as a clean bill and many important policy riders were excluded. Teva’s own Brian McCormick will soon break down UFA, what was left out, and what this means for patients at @AccessibleMeds #GrXBiosims. https://t.co/X42Gt4Ac8U — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
We’re attending the American College of Asthma, Allergy and Immunology 2022 Annual Scientific Meeting to present 6️⃣ posters highlighting our latest data from the CONNECT1 and CONNECT2 trials in #asthma management. #ACAAI22 @ACAAI #digitalhealth — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
The current regulatory framework for biosimilars and determining interchangeability within the US is not sustainable. @RachelTurow is live at #GRxBiosims discussing how we can break down unnecessary barriers and drive uptake– with savings to patients and the US healthcare system. https://t.co/mcpSJQYNiX — PolitiTweet.org
Teva Pharmaceuticals @TevaUSA
The passage of #GDUFA III signals a step in the right direction for generic access for patients and increasing competition for industry members while improving the overall healthcare infrastructure – Teva’s Brian McCormick remarked @AccessibleMeds #GRxBiosims https://t.co/8FDXWoikxz — PolitiTweet.org
